检验医学 ›› 2014, Vol. 29 ›› Issue (4): 324-326.DOI: 10.3969/j.issn.1673-8640.2014.04.005

• 临床应用研究·论著 • 上一篇    下一篇

糖化血红蛋白与骨代谢生化指标相关性的探讨

张敏,李智,魏琦,王璐   

  1. 上海市杨浦区中心医院检验科,上海 200090
  • 收稿日期:2013-11-30 出版日期:2014-04-30 发布日期:2014-06-06
  • 作者简介:张敏,女,1970年生,学士,主管技师,主要从事临床生化检验工作。

Investigation on the correlation between glycosylated hemoglobin A1c and biochemical markers of bone metabolism

ZHANG Min, LI Zhi, WEI Qi, WANG Lu   

  1. Department of Clinical Laboratory,Yangpu District Central Hospital,Shanghai 200090,China
  • Received:2013-11-30 Online:2014-04-30 Published:2014-06-06

摘要:

目的 探讨糖化血红蛋白(HbA1c)与骨代谢生化指标的相关性。方法 将2402型糖尿病患者根据HbA1c水平分为A组(HbA1c6.5%)、B组(6.5%≤HbA1c8.0%)和C组(HbA1c≥8.0%),以80名健康体检者作为正常对照组。分别测定4组骨代谢相关指标[包括血清碱性磷酸酶(ALP)、氨基端和中段骨钙素(N-MID Osteocalcin)、β-胶原特殊序列(β-CrossLaps)、甲状旁腺素(PTH)、25-羟基维生素DVit D)、总型胶原氨基端延长肽(TP1NP)、钙、磷]水平并做比较,分析HbA1c与骨代谢相关指标之间的相关性。结果 ABC 3N-MID OsteocalcinVit D均明显低于正常对照组(P0.05);Aβ-CrossLaps明显高于正常对照组(P0.05);BALPTP1NPCTP1NPβ-CrossLapsPTH均明显低于正常对照组(P0.05);BALPN-MID Osteocalcinβ-CrossLapsVit DCN-MID OsteocalcinTP1NPβ-CrossLapsPTHVit D明显低于A组(P0.05);CN-MID OsteocalcinPTH明显低于B组(P0.05),而ALP则明显升高(P0.05);其余各项指标各组间差异均无统计学意义(P>0.05)。HbA1cN-MID OsteocalcinTP1NPβ-CrossLapsPTHVit D呈负相关(rs值分别为-0.49、-0.29、-0.23、-0.21、-0.25P均<0.05)。结论 HbA1cN-MID OsteocalcinTP1NPβ-CrossLapsPTHVit D有影响。血糖控制越差,骨代谢指标N-MID OsteocalcinTP1NPβ-CrossLapsPTHVit D水平越低。2型糖尿病患者通过严格控制血糖,纠正糖代谢紊乱,可有效改善患者骨代谢。

关键词: 糖化血红蛋白, 骨代谢, 2型糖尿病

Abstract:

Objective To research the cut-off value of microalbuminuria with urine albumin to creatinine ratioACR and urinary albuminU-Alb concentration of first morning urine and random urine samples among type 2 diabetes mellitusT2DM), in order to detect early diabetic kidney diseaseDKD. Methods A total of 169 T2DM patients and 40 healthy subjectshealthy control group were enrolled. Their 24 h urine first morning urine and random urine samples were collected. The 24 h urinary albumin excretion UAE was referred as the gold standard of early DKD and the detection effectiveness of early DKD was evaluated when applied ACR and U-Alb concentration from first morning urine and random urine samples. According to receiver operating characteristic ROC curve analysis the value with the maximum Youden index was the appropriate microalbuminuria cut-off value of ACR and U-Alb concentration from first morning urine and random urine samples for detecting early DKD. Results The coincidence of ACR and U-Alb concentration with 24 h UAE from first morning urine samples were 43% and 37% and those of ACR and U-Alb concentration from random urine samples were 48% and 41% which were all significantly different with 24 h UAEP0.001. In healthy control group the microalbuminuria judgment was totally normal and consistent with 24 h UAE. ROC curve analysis indicated that the cut-off values of ACR from first morning urine samples were male 16 mg/g and female 23 mg/g Youden indices 0.7 and 0.67 negative predictive values 97% and 100% and positive predictive values 72% and 65% respestively), and those of ACR from random urine samples were male 17 mg/g and female 28 mg/gYouden indices 0.68 and 0.67 negative predictive values 90% and 90% and positive predictive values 61% and 82% respectively. Those of U-Alb concentration from first morning urine samples were male 16 mg/L and female 15 mg/LYouden indices 0.57 and 0.59 negative predictive values 84% and 87% and positive predictive values 90% and 73% respectively), and those of U-Alb concentration from random urine samples male 17 mg/L and female 14 mg/LYouden indices 0.56 and 0.53 negative predictive values 73% and 81% and positive predictive values 85% and 71% respectively. The maximum Youden index of ACR was >0.6 and better than the Youden index of U-Alb concentration. Conclusions The missing diagnosis rate is high when detecting early DKD among T2DM patients with current clinical microalbuminuria cut-off value from first morning urine and random urine samples. The cut-off values of ACR and U-Alb concentration from first morning urine and random samples should be established in order to facilitate the early prevention and treatment of DKD.

Key words: Glycosylated hemoglobin A1c, Bone metabolism, Type 2 diabetes mellitus

中图分类号: